Pulmonary sclerosing pneumocytoma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Pulmonary sclerosing pneumocytoma
Pulmonary sclerosing pneumocytoma under high magnification
Synonyms	Sclerosing hemangioma of the lung
Pronounce	N/A
Specialty	Pulmonology, Pathology
Symptoms	Often asymptomatic, but may include cough, chest pain, or hemoptysis
Complications	N/A
Onset	Typically in middle-aged adults
Duration	Chronic
Types	N/A
Causes	Unknown
Risks	More common in women
Diagnosis	Histopathology, Imaging studies
Differential diagnosis	Pulmonary hamartoma, Carcinoid tumor, Metastatic disease
Prevention	N/A
Treatment	Surgical resection
Medication	N/A
Prognosis	Excellent with complete resection
Frequency	Rare
Deaths	N/A

Pulmonary sclerosing pneumocytoma, also known as sclerosing hemangioma, is a rare benign neoplasm of the lung. It is characterized by its unique histological features and is most commonly found in middle-aged women. Despite its name, it is not related to vascular tumors but is thought to originate from primitive respiratory epithelium.

Clinical Presentation

Patients with pulmonary sclerosing pneumocytoma are often asymptomatic, and the tumor is frequently discovered incidentally during imaging studies for other conditions. When symptoms do occur, they may include cough, hemoptysis, or chest pain. Rarely, the tumor can cause respiratory distress if it grows large enough to obstruct airways.

Pathology

Pulmonary sclerosing pneumocytoma is typically a well-circumscribed, solitary mass located in the lung parenchyma. On gross examination, the tumor appears as a firm, yellowish nodule. Microscopically, it is composed of two main cell types: surface cuboidal cells and round stromal cells. The tumor exhibits a characteristic pattern of sclerosis, papillary structures, and hemorrhagic areas. The immunohistochemical profile of pulmonary sclerosing pneumocytoma is distinctive, with positive staining for epithelial markers such as TTF-1 and EMA, which supports its epithelial origin.

Diagnosis

The diagnosis of pulmonary sclerosing pneumocytoma is primarily based on histological examination of the tumor tissue. Imaging studies such as chest X-rays and CT scans can reveal a solitary pulmonary nodule, but they are not specific for this condition. A definitive diagnosis requires a biopsy or surgical resection of the lesion.

Treatment

Surgical resection is the treatment of choice for pulmonary sclerosing pneumocytoma. Given its benign nature, complete surgical excision is usually curative, and recurrence is rare. There is no role for chemotherapy or radiation therapy in the management of this condition.

Prognosis

The prognosis for patients with pulmonary sclerosing pneumocytoma is excellent, as the tumor is benign and does not metastasize. Long-term follow-up is generally not necessary after complete resection.

See also

• Lung neoplasm
• Benign tumor
• Histology
• Respiratory epithelium